On December 23, 2024 AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, will attend the 43rd Annual J.P. Morgan Healthcare Conference on January 13-16, 2025, in San Francisco, CA, and host meetings showcasing the Company’s recent accomplishments and sharing strategic plans moving forward (Press release, AbelZeta, DEC 23, 2024, View Source [SID1234649271]). The Company’s Chairman and CEO, Tony (Bizuo) Liu, has also been invited as a panel speaker at the 8th Annual BFC Global Healthcare BD and Investment Conference on Sunday, January 12, 2025.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Session: Faith to Incubate: Global Biotech Investment Trends and Focus
Time & Date: January 12, 2025, 09:15 – 10:15 PST
Location: The St. Regis San Francisco
Registration: View Source